Selective in vivo growth of lymphocyte function- associated antigen-1-positive murine myeloma cells: Involvement of function-associated antigen-1-mediated homotypic cell-cell adhesion

Experimental Hematology

Volumn 31, Issue 1, 2003, Pages 48-55

  Asosingh, Kewal ^a   Vankerkhove, Virginie ^a   Van Riet, Ivan ^a   Van Camp, Ben ^a   Vanderkerken, Karin ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM 51; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; THYMIDINE; TRITIUM;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; BONE MARROW; CELL ADHESION; CELL ASSAY; CELL COUNT; CELL CYCLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL SELECTION; CELL SURVIVAL; CELLULAR PARAMETERS; CONTROLLED STUDY; DISEASE COURSE; DNA SYNTHESIS; ENDOTHELIUM CELL; FLOW CYTOMETRY; IN VIVO STUDY; INOCULATION; LYMPHOCYTE FUNCTION; MAGNETISM; MALE; MEDICAL LITERATURE; MOUSE; MULTIPLE MYELOMA; MYELOMA; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TIME;

ANIMALS; APOPTOSIS; BONE MARROW; CELL ADHESION; CELL CYCLE; CELL DIVISION; CELL MOVEMENT; IMIDAZOLES; IMIDAZOLIDINES; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; MALE; MICE; MICE, INBRED C57BL; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; TUMOR STEM CELLS;

ANIMALIA; MURINAE;

EID: 0037238062     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00970-0     Document Type: Article

References (39)

1. Larson R.S., Hibbs M.L., Springer T.A. The leukocyte integrin LFA-1 reconstituted by cDNA transfection in a nonhematopoietic cell line is functionally active and not transiently regulated. Cell Regul. 1:1990;359-367.
2. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
3. Gahmberg C.G., Tolvanen M., Kotovuori P. Leukocyte adhesion - structure and function of human leukocyte β2-integrins and their cellular ligands. Eur J Biochem. 245:1997;215-232.
4. Hynes R.O. Integrins. Versatility, modulation, and signaling in cell adhesion Cell. 69:1992;11-25.
5. Issekutz T.B. Lymphocyte homing to sites of inflammation. Curr Opin Immunol. 4:1992;287-293.
6. Luscinskas F.W., Lawler J. Integrins as dynamic regulators of vascular function. FASEB J. 8:1994;929-938.
7. El Ghmati S.M., Van Hoeyveld E.M., Van Strijp J.G., Ceuppens J.L., Stevens E.A. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol. 156:1996;2542-2552.
8. Coxon A., Rieu P., Barkalow F.J.et al. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis. A homeostatic mechanism in inflammation Immunity. 5:1996;653-666.
9. Benimetskaya L., Loike J.D., Khaled Z.et al. Mac-1 (CD11b/CD18) is an oligodeoxynucleotide-binding protein. Nat Med. 3:1997;414-420.
10. McMurray R.W. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum. 25:1996;215-233.
11. Oppenheimer-Marks N., Lipsky P.E. Adhesion molecules as targets for the treatment of autoimmune diseases. Clin Immunol Immunopathol. 79:1996;203-210.
12. Lub M., van Kooyk Y., Figdor C.G. Ins and outs of LFA-1. Immunol Today. 16:1995;479-483.
13. Hallek M., Bergsagel P.L., Anderson K.C. Multiple myeloma. increasing evidence for a multistep transformation process Blood. 91:1998;3-21.
14. Kuehl W.M., Bergsagel P.L. Multiple myeloma. evolving genetic events and host interactions Nat Rev. 2:2002;175-187.
15. Ahsmann E.J., Lokhorst H.M., Dekker A.W., Bloem A.C. Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma. Blood. 79:1992;2068-2075.
16. Kawano M.M., Huang N., Tanaka H.et al. Homotypic cell aggregations of human myeloma cells with ICAM-1 and LFA-1 molecules. Br J Haematol. 79:1991;583-588.
17. Faid L., Van Riet I., De Waele M.et al. Adhesive interactions between tumour cells and bone marrow stromal elements in human multiple myeloma. Eur J Haematol. 57:1996;349-358.
18. Barker H.F., Hamilton M.S., Ball J., Drew M., Franklin I.M. Expression of adhesion molecules LFA-3 and N-CAM on normal and malignant human plasma cells. Br J Haematol. 81:1992;331-335.
19. Pellat-Deceunynck C., Barille S., Puthier D.et al. Adhesion molecules on human myeloma cells. significant changes in expression related to malignancy, tumor spreading, and immortalization Cancer Res. 55:1995;3647-3653.
20. Kelly T.A., Jeanfavre D.D., McNeil D.W.et al. Cutting edge. a small molecule antagonist of LFA-1-mediated cell adhesion J Immunol. 163:1999;5173-5177.
21. Radl J., De Glopper E.D., Schuit H.R., Zurcher C. Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice. J Immunol. 122:1979;609-613.
22. Asosingh K., Gunthert U., Bakkus M.H.et al. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res. 60:2000;3096-3104.
23. Vanderkerken K., De Raeve H., Goes E.et al. Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer. 76:1997;451-460.
24. Woska J.R. Jr., Shih D., Taqueti V.R., Hogg N., Kelly T.A., Kishimoto T.K. A small-molecule antagonist of LFA-1 blocks a conformational change important for LFA-1 function. J Leukoc Biol. 70:2001;324-329.
25. Imai K., Kobayashi M., Wang Ohiro Y.et al. Selective transendothelial migration of hematopoietic progenitor cells. a role in homing of progenitor cells Blood. 93:1999;149-156.
26. Cheung W.C., Van Ness B. The bone marrow stromal microenvironment influences myeloma therapeutic response in vitro. Leukemia. 15:2001;264-271.
27. Asosingh K., Gunthert U., De Raeve H., Van Riet I., Van Camp B., Vanderkerken K. A unique pathway in the homing of murine multiple myeloma cells. CD44v10 mediates binding to bone marrow endothelium Cancer Res. 61:2001;2862-2865.
28. Kim I., Uchiyama H., Chauhan D., Anderson K.C. Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines. Br J Haematol. 87:1994;483-493.
29. Mohle R., Moore M.A., Nachman R.L., Rafii S. Transendothelial migration of CD34+ and mature hematopoietic cells. An in vitro study using a human bone marrow endothelial cell line Blood. 89:1997;72-80.
30. Yong K.L., Watts M., Shaun Thomas N. Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood. 91:1998;1196-1205.
31. Schmits R., Kundig T.M., Baker D.M.et al. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med. 183:1996;1415-1426.
32. Shier P., Otulakowski G., Ngo K.et al. Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the β2 integrin leukocyte function-associated antigen-1. J Immunol. 157:1996;5375-5386.
33. Krensky A.M., Mentzer S.J., Clayberger C.et al. Heritable lymphocyte function-associated antigen-1 deficiency. abnormalities of cytotoxicity and proliferation associated with abnormal expression of LFA-1 J Immunol. 135:1985;3102-3108.
34. Vyth-Dreese F.A., Dellemijn T.A., Frijhoff A., van Kooyk Y., Figdor C.G. Role of LFA-1/ICAM-1 in interleukin-2-stimulated lymphocyte proliferation. Eur J Immunol. 23:1993;3292-3299.
35. Fagerholm S., Morrice N., Gahmberg C.G., Cohen P. Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. J Biol Chem. 277:2002;1728-1738.
36. Laronga C., Yang H.Y., Neal C., Lee M.H. Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem. 275:2002;23106-23112.
37. Lokhorst H.M., Lamme T., de Smet M.et al. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood. 84:1994;2269-2277.
38. Gadek T.R., Burdick D.J., McDowell R.S.et al. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule. Science. 295:2002;1086-1089.
39. Shannon J.P., Silva M.V., Brown D.C., Larson R.S. Novel cyclic peptide inhibits intercellular adhesion molecule-1-mediated cell aggregation. J Pept Res. 58:2001;140-150.